A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 80.40
+0.40 (0.50%)
At close: Mar 27, 2026
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.71 billion as of March 27, 2026. Its market cap has decreased by -10.65% in one year.
Market Cap
2.71B
Enterprise Value
2.20B
Revenue
835.89M
Ranking
n/a
PE Ratio
15.61
Stock Price
80.40
Market Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.71B, an increase of 77.81%. That is a compound annual growth rate of 19.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.71B | -8.35% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonraybio | 4.12B |
| WeLeader Biomedical | 3.11B |
| Medimaging Integrated Solution | 2.87B |
| Dynamic Medical Technologies | 2.44B |
| Applied BioCode | 2.40B |
| Wellell | 2.25B |
| Taiwan Biomaterial | 1.89B |
| OK Biotech | 1.88B |